There has been a shortage of Ozempic, a weight loss drug to help those with type 2 diabetes control their appetites, because rich people began to get it "prescribed" by physicians as a diet tool.
That may be why the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for those with obesity but stating - which means they are telling doctors who cater to rich people - it is for those with at least one weight-related condition like high blood pressure, type 2 diabetes or high cholesterol. This is a broader approval than Tirzepatide already approved under the trade name Mounjaro which was only for adults with type 2 diabetes mellitus. Any doctor will sign off on 'high' blood pressure pr 'high' cholesterol, since those are population-level risk factors for risk factors for disease and not clinically relevant on their own.
If you got Ozempic face due to wanting magical solutions to your overeating, trying a magical cream, like Aestha
But if you are using it as a crash diet, use some judgment. You don't want 'Ozempic face' like some have had, and then feel the need to get fillers to offset that.
If you really want to try an alternative diet only risked by the fringes of the health community, simply eat fewer calories.
Move Over Ozempic. FDA Has Approved A New Weight Loss Injection Celebrities Will Exploit
Related articles
- Ozempic, Wegovy, and Mounjaro Have Helped The Rich Create New Healthcare Sneetch Stars
- Type 2 Diabetes Medication Tirzepatide May Help Obese Type 1 Diabetics Also
- Ozempic, Wegovy and Rybelsus Are So Popular That Eating Less Is A Fringe Alternative Diet
- With Insurance Companies Cracking Down On Fake Ozempic Prescriptions, Supplement Grifters Sell Berberine
- Just Correlation, Not Science: Ozempic 'Leads' To Less Dementia
Comments